Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 18.92
+0.44 (2.38%)
Oct 22, 2026, 5:35 PM CEST
EPA:BLC Ratios and Metrics
Market cap in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 140 | 175 | 232 | 134 | 209 | 258 | |
Market Cap Growth | -20.10% | -24.63% | 73.08% | -35.80% | -19.05% | -25.65% |
Enterprise Value | 391 | 473 | 623 | 536 | 610 | 586 |
Last Close Price | 18.92 | 23.60 | 31.30 | 18.10 | 28.60 | 35.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 2.41 | 3.01 | 439.54 | - | 17.34 | 18.86 |
Forward PE | 11.13 | 13.76 | 10.15 | 6.01 | 8.91 | 12.44 |
PS Ratio | 0.29 | 0.36 | 0.47 | 0.29 | 0.41 | 0.55 |
PB Ratio | 1.07 | 1.34 | 3.26 | 1.66 | 2.37 | 2.98 |
P/FCF Ratio | 2.52 | 3.14 | 5.56 | 5.48 | 4.01 | 71.95 |
P/OCF Ratio | 1.31 | 1.64 | 2.28 | 1.81 | 1.98 | 4.54 |
PEG Ratio | - | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.81 | 0.98 | 1.27 | 1.16 | 1.20 | 1.25 |
EV/EBITDA Ratio | 3.57 | 4.32 | 7.50 | 7.13 | 7.35 | 7.37 |
EV/EBIT Ratio | 8.17 | 9.90 | 13.79 | 13.92 | 14.24 | 15.04 |
EV/FCF Ratio | 7.02 | 8.50 | 14.93 | 21.92 | 11.72 | 163.31 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 2.29 | 2.29 | 5.77 | 5.06 | 4.85 | 4.84 |
Debt / EBITDA Ratio | 2.73 | 2.73 | 4.00 | 4.36 | 4.21 | 4.26 |
Debt / FCF Ratio | 5.37 | 5.37 | 9.85 | 16.71 | 8.21 | 116.91 |
Net Debt / Equity Ratio | 1.92 | 1.92 | 5.41 | 4.77 | 4.43 | 4.58 |
Net Debt / EBITDA Ratio | 2.29 | 2.29 | 4.64 | 5.12 | 4.71 | 4.99 |
Net Debt / FCF Ratio | 4.51 | 4.51 | 9.24 | 15.74 | 7.51 | 110.74 |
Asset Turnover | 0.78 | 0.78 | 0.75 | 0.71 | 0.79 | 0.78 |
Inventory Turnover | 3.99 | 3.99 | 3.80 | 3.34 | 3.60 | 3.54 |
Quick Ratio | 0.94 | 0.94 | 0.70 | 0.68 | 0.64 | 0.75 |
Current Ratio | 1.20 | 1.20 | 1.38 | 0.97 | 0.87 | 1.07 |
Return on Equity (ROE) | 9.89% | 9.89% | 5.32% | 7.71% | 19.23% | 17.57% |
Return on Assets (ROA) | 4.83% | 4.83% | 4.32% | 3.69% | 4.15% | 4.05% |
Return on Invested Capital (ROIC) | 8.59% | 7.82% | 3.76% | 4.04% | 6.57% | 6.26% |
Return on Capital Employed (ROCE) | 11.70% | 11.70% | 9.80% | 8.90% | 9.90% | 8.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 41.43% | 33.21% | 0.23% | -0.67% | 5.77% | 5.30% |
FCF Yield | 39.70% | 31.83% | 17.99% | 18.24% | 24.92% | 1.39% |
Payout Ratio | 0.95% | 0.95% | - | - | - | 16.36% |
Buyback Yield / Dilution | - | - | 0.04% | -0.04% | -7.66% | -0.22% |
Total Shareholder Return | - | - | 0.04% | -0.04% | -7.66% | -0.22% |